Center for Infectious Diseases, Nara Medical University, Kashihara, Japan.
Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara, Japan.
PLoS One. 2019 Nov 13;14(11):e0225210. doi: 10.1371/journal.pone.0225210. eCollection 2019.
Almost all cases of carbapenemase-producing Enterobacteriaceae infections in Japan are caused by blaIMP-positive Enterobacteriaceae (especially blaIMP-6) and infections caused by other types of carbapenemase-producing Enterobacteriaceae are quite rare. We examined drug resistance genes co-harboring with blaIMP-6 and their inoculum size effects. We screened β-lactamase genes, plasmid-mediated quinolone resistance (PMQR) genes, and aminoglycoside-modifying enzyme genes by PCR and performed sequencing for 14 blaIMP-6-positive Enterobacteriaceae. Further, all PMQR-positive isolates were submitted to conjugation and inoculum effect evaluation. Our data showed that 13 of the 14 isolates harbored CTX-M-2 and one co-harbored CTX-M-2 and CTX-M-1 as extended-spectrum β-lactamases. All isolates carried one or more PMQRs; aac(6')-Ib-cr was the most prevalent (92.8%), and was followed by oqxA (64.3%), qnrS (50%), oqxAB (21.4%), and qnrB (14.3%). However, Klebsiella pneumoniae contains chromosomal OqxAB. Inoculum size effects were significant in all strains for meropenem, 13 strains for imipenem, 7 for levofloxacin, and 3 for amikacin. We observed that 11 of the experimental strains (100%), 8 strains (72.7%), and 1 strain showed inoculum size effects for meropenem, imipenem, and amikacin, respectively. However, four strains harbored qnr genes and two strains harbored qnr genes and QRDR mutations concurrently; no inoculum size effect was seen for levofloxacin. The blaIMP-6-positive Enterobacteriaceae that we studied was found to harbor at least one plasmid-mediated drug resistance gene. The inoculum size effect for carbapenems was thought to be mainly due to IMP-6-type metallo-β-lactamase; however qnrB and qnrS also had a minimal impact on the inoculum size effect for levofloxacin.
在日本,几乎所有碳青霉烯酶产生肠杆菌科感染病例都是由 blaIMP 阳性肠杆菌科(尤其是 blaIMP-6)引起的,而由其他类型碳青霉烯酶产生肠杆菌科引起的感染则相当罕见。我们检查了与 blaIMP-6 共同携带的耐药基因及其接种物大小效应。我们通过 PCR 筛选了β-内酰胺酶基因、质粒介导的喹诺酮耐药(PMQR)基因和氨基糖苷修饰酶基因,并对 14 株 blaIMP-6 阳性肠杆菌科进行了测序。此外,所有 PMQR 阳性分离株均进行了接合和接种物效应评估。我们的数据显示,14 株分离株中有 13 株携带 CTX-M-2,1 株同时携带 CTX-M-2 和 CTX-M-1 作为超广谱β-内酰胺酶。所有分离株均携带一种或多种 PMQR;aac(6')-Ib-cr 最为常见(92.8%),其次是 oqxA(64.3%)、qnrS(50%)、oqxAB(21.4%)和 qnrB(14.3%)。然而,肺炎克雷伯菌含有染色体 OqxAB。所有菌株对美罗培南、13 株对亚胺培南、7 株对左氧氟沙星和 3 株对阿米卡星的接种物大小效应均有显著影响。我们观察到 11 株实验株(100%)、8 株(72.7%)和 1 株分别对美罗培南、亚胺培南和阿米卡星表现出接种物大小效应。然而,有 4 株携带 qnr 基因,有 2 株同时携带 qnr 基因和 QRDR 突变,对左氧氟沙星没有接种物大小效应。我们研究的 blaIMP-6 阳性肠杆菌科至少携带一种质粒介导的耐药基因。碳青霉烯类药物的接种物大小效应主要归因于 IMP-6 型金属β-内酰胺酶;然而,qnrB 和 qnrS 也对左氧氟沙星的接种物大小效应有一定影响。